OSAPQ — ProSomnus Income Statement
0.000.00%
- $0.24m
- $27.59m
- $27.65m
- 17
- 64
- 12
- 22
Annual income statement for ProSomnus, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 8.29 | 14.1 | 19.4 | 27.7 |
Cost of Revenue | ||||
Gross Profit | 4.12 | 7.31 | 10.3 | 14 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Unusual Expense / Income | ||||
Total Operating Expenses | 12.4 | 16.6 | 33.5 | 57.2 |
Operating Profit | -4.16 | -2.54 | -14.1 | -29.6 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -6.16 | -5.98 | -7.15 | -24.1 |
Provision for Income Taxes | ||||
Net Income After Taxes | -6.17 | -5.98 | -7.15 | -24.1 |
Net Income Before Extraordinary Items | ||||
Net Income | -6.17 | -5.98 | -7.15 | -24.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -6.17 | -5.98 | -7.15 | -24.1 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.385 | -0.515 | -0.454 | -0.813 |